menu
    • menu

    Company profile for Ascendis Pharma

    NEW Drugs in Dev: 10
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ascendis Pharma is applying its innovative TransCon technology, which combines the benefits of prodrug and sustained-release technologies, to develop a pipeline of best‐in‐class therapeutics that address significant unmet medical needs. The TransCon technology can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs that provide for the predictable and sustained releas...
    Ascendis Pharma is applying its innovative TransCon technology, which combines the benefits of prodrug and sustained-release technologies, to develop a pipeline of best‐in‐class therapeutics that address significant unmet medical needs. The TransCon technology can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ascendis PharmaDenmark Flag
    Country
    Country
    Denmark
    Address
    Address
    Tuborg Boulevard 12 2900 Hellerup Denmark
    Telephone
    Telephone
    +45 70 22 22 44
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ascendispharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ascendis-pharma-a-s/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ascendis Reports Q1 2026 Results on May 7
    Ascendis Reports Q1 2026 Results on May 7

    30 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/30/3285424/0/en/ascendis-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-may-7-2026.html

    GLOBENEWSWIRE
    30 Apr 2026
    Share Share
    Ascendis Pharma To List Ordinary Shares Directly On Nasdaq
    Ascendis Pharma To List Ordinary Shares Directly On Nasdaq

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3270368/0/en/Ascendis-Pharma-to-List-Ordinary-Shares-Directly-on-Nasdaq.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    TransCon HGH Boosts TransCon CNP in Achondroplasia
    TransCon HGH Boosts TransCon CNP in Achondroplasia

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3270080/0/en/New-Data-from-Week-52-of-the-Ongoing-COACH-Trial-Showed-that-TransCon-hGH-Accelerated-TransCon-CNP-s-Benefits-Beyond-Linear-Growth-in-Children-with-Achondroplasia.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    Ascendis Launches Yuviwel with Orphan Drug Exclusivity in US
    Ascendis Launches Yuviwel with Orphan Drug Exclusivity in US

    06 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/06/3268705/0/en/Ascendis-Receives-Orphan-Drug-Exclusivity-and-Launches-YUVIWEL-Navepegritide-in-the-United-States.html

    GLOBENEWSWIRE
    06 Apr 2026
    Share Share
    Revolution, Ascendis Seen As Top Buyout Targets In Biopharma
    Revolution, Ascendis Seen As Top Buyout Targets In Biopharma

    19 Mar 2026

    // BIOSPACE

    https://www.biospace.com/business/as-analysts-await-pharma-on-pharma-megadeals-biotechs-offer-attractive-alternatives-for-the-cautious

    BIOSPACE
    19 Mar 2026
    Share Share
    TransCon hGH Matches Somatropin in InsiGHTS Turner Trial
    TransCon hGH Matches Somatropin in InsiGHTS Turner Trial

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257185/0/en/New-InsiGHTS-Trial-of-TransCon-hGH-Lonapegsomatropin-in-Turner-Syndrome-Demonstrated-Comparable-Efficacy-and-Safety-to-Daily-Somatropin-at-Week-52.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search